Latest Underwriting News

News Corporation has priced a significant secondary offering of over 14 million Class B shares at $32.45 each, marking a notable move by key Murdoch family trusts. The company itself is not raising capital, with proceeds going solely to selling stockholders.

News Corporation has settled longstanding legal disputes involving the Murdoch Family Trust and announced a significant secondary offering of Class B shares by departing family beneficiaries.

News Corporation’s Murdoch Family Trust is selling 14.2 million Class B shares in a significant secondary offering, marking a pivotal step in a broader ownership restructuring that reshapes voting control and family interests.

News Corporation has announced a significant secondary offering of over 14 million Class B shares by key family trusts, signaling a notable insider sell-down without direct proceeds to the company.

SkyCity Entertainment Group has successfully completed a NZ$240 million equity raise through a fully underwritten entitlement offer, with retail shareholders subscribing to one-third of their entitlements. New shares will begin trading next week on both the NZX and ASX.

Tasmea Limited has launched a $43 million institutional placement to strengthen its balance sheet for future acquisitions, following a robust FY25 with significant profit growth and margin expansion. The company’s FY26 guidance signals continued momentum driven by organic growth and strategic acquisitions.

Kuniko Limited updates its prospectus to extend its entitlement offer, enter a joint venture for the Commonwealth Project, and secure partial underwriting from GBA Capital.

Kuniko Limited has launched a partially underwritten rights issue to fund exploration at its Commonwealth Gold-Silver Project in New South Wales, aiming to capitalise on high-grade multi-metal potential in a Tier-1 jurisdiction.

Coda Minerals has announced a fully underwritten $8.33 million entitlement offer to fund the pre-feasibility study of its Elizabeth Creek Copper-Silver Project, offering shareholders a discounted entry price with attaching options.

Pathkey.AI’s TrialKey platform has demonstrated a 73% alignment with actual biotech trial outcomes, showing an average hypothetical share price gain of 76%, underscoring AI’s growing role in clinical trial prediction and biotech investing.

Matsa Resources has entered an underwriting agreement to guarantee the exercise of up to 10 million unlisted options expiring this September, potentially raising $700,000 in fresh capital.

Evolution Energy Minerals has announced that its recent entitlement offer is now fully underwritten by Mahe Capital, with key directors participating as sub-underwriters, removing previous minimum subscription conditions.